Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Veracyte Inc 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

P: 650-243-6300 F: 650-243-6388

Description:

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 1,045,656
Shares Outstanding, K 41,643
Annual Sales, $ 92,010 K
Annual Net Income, $ -23,000 K
Last Quarter Sales, $ 29,530 K
Last Quarter Net Income, $ -1,920 K
60-Month Beta 0.95
% of Insider Shareholders 13.70%
% of Institutional Shareholders 87.47%
Float, K 35,938
% Float 86.30%

Growth:

1-Year Return 272.94%
3-Year Return 363.69%
5-Year Return 65.81%
5-Year Revenue Growth 320.52%
5-Year Earnings Growth 89.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/30/19
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 81.48%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

VCYT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -10.51
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -23.43
Return-on-Assets (Before Tax) -14.69
Profit Margin % -25.00
Net Margin % N/A
Debt/Equity 0.30
Price/Sales 11.36
Price/Cash Flow N/A
Price/Book 12.48
Book Value/Share 2.01
Interest Coverage -10.73
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar